About
I co-founded ProxDeal to bring data depth and automation to a world that badly needed it: M&A and PE in the DACH region. While global top players increasingly rely on structured data and software-driven workflows, many firms here still operate with low-quality sources, shallow databases, and manual processes. Today, ProxDeal sets the gold standard for target and buyer research in Germany offering the deepest data foundation and a high-performance emulation of analyst work. Beyond M&A, ProxDeal is becoming increasingly relevant for other verticals as well, due to the unique data signals we provide. Our API makes this data programmatically accessible for automated workflows. Before ProxDeal, I helped build and scale several technology companies, including as first employee of a life sciences buy-and-build platform that IPO’ed on NASDAQ at a multi-billion dollar valuation. I also founded a niche tech M&A boutique, led a German real estate group, and worked across VC and high-growth startu…
Experience
Co-Founder & Managing Director (Ceo)
Present
ProxDeal is an AI-agent-based high-performance tool designed for M&A professionals, simplifying research and buyer/target identification. Tailored for sell-side and buy-side processes, ProxDeal is the new gold standard for data-driven M&A. proxdeal.com
Founder & Managing Director
Present
Tech M&A situations. Selective mandates only. sigubald.com
Founding Advisor
Present
Pheiron uses AI and population-scale data to build evidence for safe and effective drugs.
Managing Director
Real estate investments & development. Also Managing Director of affiliated company Immoraising Capital Partners GmbH.
Venture & Investment Manager
Focused on M&A and managed portfolio of more than 15 different companies (of which 1 IPO’ed at a $2bn valuation) incl. oversight on strategic topics, board matters and follow-up financing rounds.
Investment & Business Development Associate (Employee #1)
ATAI Life Sciences is an internationally active biotech company developing innovative mental health treatments that address significant unmet medical needs. Joined founder and CEO as first employee. Company IPO'ed on NASDAQ in June 2021 (ticker: ATAI) at a valuation of $2.6bn. Involved in all business-related aspects of the company and helped to scale company to over 100 employees.
Operations Lead
EntheogeniX Biosciences
Entheogenix Biosciences is an AI-based biotech compound generation engine based on proteomics and focused on mental health disorders. Involved in strategy, operations, finance and board matters. Oversaw the creation of new ventures based on proprietary molecules which resulted in various clinical trials.
Aquisitions & Operations
Europe’s first SFR housing platform for institutional investors (deploying $2.5bn in institutional capital). Launched German real estate investment company together with Head of Germany.
Business Development
Kaia is the largest musculoskeletal health platform in the world. Set up corporate sales in the early days of the company. Acquired by Sword Health for $285m.
Vc | Allianz Ventures
Allianz · München
Former corporate venture capital arm of Allianz. VC focused on health and connected property.
Education
Imperial College London
MSc, Master of Science
Ludwig-Maximilians-Universität München
BSc, Bachelor of Science
University of Regensburg
Human Medicine
German High School (Gymnasium)
German High School Diploma (Abitur)
Find leads like Simon
Origami finds your ideal customers across 15+ data sources with a single prompt.
Try Origami Free